Abstract
Essentially, the term ‘biobank’ can be defined in different ways. Taking the UK Biobank’s experience as the main example, the Taiwan Biobank aims to collect the DNA of a large group of people on the population base and track their health and lifestyle for at least 10 years. It is hoped that the information collected, regarding the mechanisms underlying how genes and environmental factors interact with each other to make us ill, will benefit the society in various ways, including the exploration of a new generation of treatments, support to preventive medicine discovery and also the possible benefits for the promotion of evolving public health-related industries in Taiwan. However, the involvement of large-scale population base gene data collection also triggered serious ethical, legal and social issues. In Taiwan, the challenge is even more serious than for any other biobanking experiences that have occurred previously. Among all the ethical, legal and social issues, the convergence of aboriginal people protection provided under Taiwan’s Constitution imposes on the research team an obligation to create an innovative Ethical & Legal Governance Framework adaptable to the unique social background of Taiwan, including a workable public consultation/communication mechanism. In early 2005, the creation of the ‘Taiwan Biobank’ has been included as a part of Taiwan’s strategic development in promoting the country as an island of biomedicine. In this report, the ideology, the goals and special features, government strategy, visions and, in particular, the ethical, legal and social issue planning of the Taiwan Biobank will be briefly introduced and reviewed.
Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
Bibliography
- 1 UN Educational, Scientific and Cultural Organization: Universal Declaration on the Human Genome and Human Rights. Art. 14 (rev. 11) (1997).
- 2 Yang HC, Lin CH, Hsu CL et al.: A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J. Biomed. Sci.13(4),489–498 (2006).• Investigated the population admixture and phylogenetic system in Han Chinese residing in Taiwan and found that Taiwan’s Han Chinese are relatively homogenous among the three major ethnic groups: Ho-ló (Minnan), Hakka and Mainlanders. The study has been critical to the disease gene-mapping studies of Taiwan.
- 3 Easton DF, Pooley KA, Dunning AM et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature447,1087–1093 (2007).• This research aims to identify other susceptibility common alletes, other than those known susceptibility genes, which may account for the familial risk of breast cancer.
- 4 UN Educational, Scientific and Cultural Organization: International Declaration on Human Genetic Data. Art. 24 (rev. 10) (2003).
- 101 Feasibility Study of Taiwan Biobank (Accessed 15 July 2007) www.twbiobank.org.tw/nsc/
- 102 Pilot Research Plan for Taiwan Biobank Development (Accessed 20 July 2007) www.twbiobank.org.tw/
- 103 The Ho-ló, accounting for 73.3% of the Taiwanese population, originated from central China and immigrated into south eastern China before the Tang Dynasty (BC 618–907) (Accessed 18 July 2007) http://zh.wikipedia.org/wiki/%E9%B6%B4%E4%BD%AC%E4%BA%BA
- 104 The Hakkas, accounted for 13.4% of the Taiwanese population, are a unique ethnic group of ‘Han’ Chinese originally active around the Yellow River area. They are thought to be one of the earliest Han settlers in China (Accessed 18 July 2007) www.asiawind.com/hakka/
- 105 Academia SINICA (Accessed 18 July 2007) www.sinica.edu.tw/main.shtml
- 106 Department of Health (Accessed 18 July 2007) www.doh.gov.tw/CHT2006/index_ populace.aspx
- 107 MedicineNet.com, Definition of Biomarker (Accessed 10 November 2007) www.medicinenet.com/script/main/alphaidx.asp?p=k_pharm
- 108 Pharmacogenomics: Personalizing Medicine, Discovery’s Edge: Custom-fitting a Drug for a Child with Leukemia. Mayo Clinic’s Online Research Magazine (Accessed 10 November 2007) http://discoverysedge.mayo.edu/pharmacogenomics/
- 109 Human Genome Project Information www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml#whatis
